title: Current and future care of patients with the cancer anorexia-cachexia syndrome.
abstract: Many important advances have occurred in the field of cancer cachexia over the past decade, including progress in understanding the mechanisms of the cancer anorexia-cachexia syndrome (CACS) and the development of promising pharmacologic and supportive care interventions. However, no approved agents for cancer cachexia currently exist, emphasizing the unmet need for an effective pharmacologic therapy. This article reviews the key elements of CACS assessment in daily practice, the contribution of nutritional impact symptoms (NIS), the evidence for current pharmacologic options, and promising anticachexia agents in perclinical and clinical trials. It also proposes a model for multimodality therapy and highlights issues pertinent to CACS in patients with pancreatic, gastric, and esophageal cancer.
authors.affiliation: From the Palliative Care Program, Virginia Commonwealth University, Richmond, VA.
authors.forename: Egidio
authors.initials: E
authors.lastname: Del Fabbro
mesh_terms: D000855:Anorexia / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology*; D002100:Cachexia / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans; D009369:Neoplasms / Q000150:complications* / Q000188:drug therapy; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic